Glenmark Pharma will be reporting its fourth quarter numbers today. The company is expected to report a revenue growth of 15 percent, EBITDA seen up at 37.7 percent, Margins seen up at 17.2 percent and profit growth of 50 percent at over Rs 227 crore year on year.
